SEPMAG & Apis Biotechnology look to Chinese IVD market

SEPMAG, a manufacturer of biomagnetic separation systems for the in vitro diagnostics sector, and Apis Biotechnology gave a joint presentation at the State sponsored Clinical Laboratory Provider & Blood Transfusion Equipment Expo, held on March 11th in the Xi¡¯an Greenland Pico International Convention & Exhibition Centre, Shanxi province, China.

The company was recently awarded a patent from China’s State Intellectual Property Office (SIPO), and marks the Company’s intentions to further expand revenues in China - a market still in its infancy, but forecast by analysts to expand at double digit pace over the coming years. As previously reported, SEPMAG has already commenced shipping the SEPMAG Q250ml to CapitalBio, its first client in the region, for the production of its IVD kits.

SEPMAG CEO, Josep Maria Simalso held a seminar on Apis Biotechnology’s stand, explaining how homogeneous separation techniques could help assist rapid growth amongst the Country’s newly established in vitro diagnostic companies. “The Chinese government is keen to develop China’s own diagnostics technologies and advance the IVD market within the country.

The Chinese market has tremendous growth potential and the company is on the cusp of an explosion of new developments in this field. Using our technologies they will be able to develop more consistent and reliable and safer results with reduced bead aggregation. This will undoubtedly help to facilitate the growth of China’s IVD industry and we look forward to advancing research for the betterment of healthcare in the region,” he said.

The joint presentation by Apis Biotechnology and SEPMAG was given at the conference organised by the Chinese Association for Clinical Laboratory Providers (CACLP), attended by high level life science audiences from across China. The event is sponsored by the National Association of Health Industry and Enterprise Management and the Chinese Association for Clinical Laboratory Providers. Moreover, the expo is supported by the Chinese Technical Committee of Clinical Laboratory Testing, together with the In Vitro Diagnostics Standardisation Administration of China.